Pharmacy Podcast Episode 162: Nirsevimab: Prevent RSV or Let it Be?

• 2024

  Log in to bookmark this resource.

  Log in
• Sara Thompson

---

Access Resources

• LectureEN
• Ask aRCie About This Resource

About

This podcast discusses nirsevimab and its role in preventing respiratory syncytial virus (RSV) in infants. Kimberly James, PharmD discusses which patients could benefit from nirsevimab, in addition to the potential effects of using nirsevimab to prevent RSV on current practices.

---

Tags

Focus Area: Infectious Disease

Audience: Physicians

Emergency Management Stage: Preparedness (Prevention / Protection)

Bundles: Nirsevimab Library

Keywords: Infant; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Antibodies, Monoclonal, Humanized

Institutions: Mayo Clinic

---

More like this

Pharmacy Podcast Episode 162: Nirsevimab: Prevent RSV or Let it Be? 2024 · Mayo Clinic Nirsevimab-alip (Intramuscular Route) 2024 · Mayo Clinic, Merative Respiratory Syncytial Virus Prevention: A New Era of Vaccines 2023 · Jiangsu University, University of Massachusetts, Mayo Clinic, Johns Hopkins University, Rochester Regional Health, Mir Neurology

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---